Novo Nordisk A/S (NVO)
60/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $220.5B
- P/E
- 11.9
- Sector Median P/E
- 25.3
- F-Score
- 4/9
- ROIC
- 12.9%
- FCF Yield
- 2.1%
NVO has a Tessera Quality Score of 59, placing it in the top 50% of the Healthcare sector. Its P/E of 11.9 is 53% below the Healthcare sector median (25.3). Piotroski F-Score is 4/9; trailing ROIC is 12.9%.
Sector Peers
- Eli Lilly and Company (LLY)Mkt Cap: $1.14T · FCF: 18.8%
- Johnson & Johnson (JNJ)Mkt Cap: $633.2B · FCF: 18.2%
- AbbVie Inc. (ABBV)Mkt Cap: $461.3B · FCF: 27.5%
- Merck & Co., Inc. (MRK)Mkt Cap: $319.9B · FCF: 21.5%
- Novartis AG (NVS)Mkt Cap: $305.1B · FCF: 29.2%